Biogen Inc. (BIIB) Social Stream



Biogen Inc. (BIIB): $298.66

1.53 (+0.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BIIB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 373

in industry

BIOGEN INC (BIIB) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BIOGEN INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-28 27 $502 $259 $368.074 $297.13 23.88%
2021-11-19 27 $502 $209 $363.678 $297.13 22.4%
2021-11-30 27 $502 $209 $362.607 $297.13 22.04%
2021-12-08 27 $502 $209 $359.448 $297.13 20.97%
2021-12-09 28 $502 $209 $355.8 $297.13 19.75%
2021-12-21 28 $502 $209 $352.344 $297.13 18.58%
2021-12-22 28 $502 $209 $341.466 $297.13 14.92%
2021-12-23 28 $502 $209 $340.133 $297.13 14.47%
2022-01-07 28 $500 $209 $332.266 $297.13 11.83%
2022-01-13 29 $500 $195 $316.548 $297.13 6.54%
2022-01-14 29 $500 $195 $315.58 $297.13 6.21%
2022-01-18 29 $500 $195 $309.709 $297.13 4.23%
2022-01-28 30 $500 $195 $305.129 $297.13 2.69%
2022-02-02 29 $500 $195 $305.129 $297.13 2.69%
2022-02-04 30 $500 $185 $299.483 $297.13 0.79%
2022-02-08 30 $500 $185 $287.1 $297.13 -3.38%
2022-02-15 30 $500 $185 $286.333 $297.13 -3.63%
2022-02-25 30 $500 $185 $286.066 $297.13 -3.72%
2022-03-03 30 $500 $185 $286.766 $297.13 -3.49%
2022-03-08 30 $500 $185 $284.066 $297.13 -4.4%
2022-03-11 30 $500 $185 $284.3 $297.13 -4.32%
2022-03-28 30 $500 $185 $284.133 $297.13 -4.37%
2022-03-31 29 $500 $185 $287 $297.13 -3.41%
2022-04-08 29 $500 $185 $283.448 $297.13 -4.6%
2022-04-12 29 $500 $185 $281.275 $297.13 -5.34%
2022-04-18 28 $440 $185 $273.555 $297.13 -7.93%
2022-04-22 28 $440 $185 $272.52 $297.13 -8.28%
2022-04-26 27 $440 $185 $272.52 $297.13 -8.28%
2022-05-03 28 $440 $188 $272.624 $297.13 -8.25%
2022-05-05 28 $440 $185 $271.175 $297.13 -8.74%
2022-05-09 28 $440 $185 $269.396 $297.13 -9.33%
2022-06-01 28 $440 $185 $271.182 $297.13 -8.73%
2022-06-14 22 $423 $185 $257.35 $297.13 -13.39%
2022-07-22 23 $350 $183 $247.444 $297.13 -16.72%
2022-08-13 22 $350 $183 $247.764 $297.13 -16.61%
2022-09-17 22 $350 $183 $247.484 $297.13 -16.71%
2022-09-26 22 $350 $183 $247.284 $297.13 -16.78%
2022-09-28 24 $360 $200 $256.044 $297.13 -13.83%
2022-09-30 24 $360 $200 $273.364 $297.13 -8%
2022-10-06 25 $360 $200 $277.764 $297.13 -6.52%
2022-10-07 25 $360 $202 $280.764 $297.13 -5.51%
2022-10-24 25 $360 $202 $285.244 $297.13 -4%
2022-10-26 26 $360 $202 $287.754 $297.13 -3.16%
2022-10-27 27 $370 $202 $294.244 $297.13 -0.97%
2022-11-01 27 $370 $202 $293.503 $297.13 -1.22%
2022-11-11 27 $370 $215.1 $296.119 $297.13 -0.34%
2022-11-15 27 $370 $215.1 $301.196 $297.13 1.37%
2022-11-21 27 $370 $215.1 $302.157 $297.13 1.69%
2022-11-30 27 $370 $215.1 $303.273 $297.13 2.07%
2022-12-16 27 $370 $215.1 $309.542 $297.13 4.18%
2023-01-09 27 $370 $215.1 $308.773 $297.13 3.92%
2023-01-23 27 $370 $215.1 $308.85 $297.13 3.94%
2023-01-24 27 $370 $215.1 $309.619 $297.13 4.2%
2023-01-27 27 $370 $215.1 $313.58 $297.13 5.54%
2023-02-09 27 $370 $249 $321.708 $297.13 8.27%
2023-02-16 27 $370 $249 $322.166 $297.13 8.43%
2023-03-14 27 $370 $249 $323.083 $297.13 8.73%
2023-03-31 27 $370 $249 $322.791 $297.13 8.64%
2023-04-05 27 $370 $249 $322.375 $297.13 8.5%
2023-04-12 27 $370 $249 $321.791 $297.13 8.3%
2023-04-17 27 $370 $263 $322.375 $297.13 8.5%
2023-04-20 27 $370 $263 $325.125 $297.13 9.42%
2023-04-21 27 $370 $263 $325.333 $297.13 9.49%
2023-04-26 27 $370 $263 $325.166 $297.13 9.44%
2023-04-27 27 $371 $263 $326.041 $297.13 9.73%
2023-05-01 27 $371 $263 $329.375 $297.13 10.85%
2023-05-02 27 $371 $263 $330.416 $297.13 11.2%
2023-05-03 27 $371 $263 $331.25 $297.13 11.48%
2023-05-04 27 $371 $263 $332.291 $297.13 11.83%
2023-05-22 27 $371 $263 $331.521 $297.13 11.57%

The Trend in the Analyst Price Target


Over the past 15 months, BIIB's average price target has gone up $47.46.

BIIB reports an average of 13.67% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-06-01 28 440 185.0 271.182 200.00 35.59%
2022-07-22 24 350 183.0 247.444 206.25 19.97%
2022-10-06 25 360 200.0 277.764 262.26 5.91%
2023-01-23 27 370 215.1 308.850 291.93 5.8%
2023-02-16 27 370 249.0 322.166 271.53 18.65%

BIIB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.59 18 2 7 0 0 27

The Trend in the Broker Recommendations


Over the past 40 months, BIIB's average broker recommendation rating improved by 0.96.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, BIOGEN INC's number of analysts covering the stock is higher than 8481.77% of them.
  • In the context of Pharmaceutical Products stocks, BIOGEN INC's average analyst price target is higher than 8371.48% of them.
  • In the context of Pharmaceutical Products stocks, BIOGEN INC's upside potential (average analyst target price relative to current price) is greater than 824.38% of them.
  • In terms of how BIOGEN INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -5937.88% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIOGEN INC are TECH, RGEN, and AMGN.

What is the outlook for BIIB? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 6.2353 seconds.